{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:26:01Z","timestamp":1788805561658,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This aim of this study was to investigate the prognostic significance of KIT exon 11 mutation subtypes in patients with GISTs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 233 consecutive patients diagnosed with GISTs at the First Affiliated Hospital of Zhengzhou University from January 2013 to August 2018 were included in this study. The prevalence and mutation landscape of exon 11 in KIT was presented. The clinicopathological characteristics and prognosis among the different mutation subtypes were analyzed. All the statistical analyses were performed by SPSS22.0.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Somatic mutational analysis indicated that point mutations were the most frequently detected mutations followed by deletions &amp;amp; compound mutations and insertion and tandem duplication mutations in the stomach. Point mutations showed a low mitotic count and a high risk of recurrence, and deletions and compound mutations have a high mitotic count while insertions and tandem duplication mutations showed a low mitotic count with an intermediate recurrence risk. Point mutations and deletions frequently occurred in sequence region codons 550-560 of exon 11, while compound mutations, insertion, and tandem duplication were mainly detected in codons 557-559, 572-580, and 577-581, respectively. The multi-variation analysis demonstrated that tumor diameter and high recurrence risk groups had worse prognostic values. However, mutation types were not significant predictors of relapse-free survival (RFS) in GISTs. Survival analysis suggested no significant difference in RFS between the 557\/558 deletion and the other deletions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggested that mutations in exon 11 of the KIT gene were common with intermediate\/high recurrence risk in GISTs patients. Tumor diameter \u22655 cm, and deletions mutations might predict a worse prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1272046","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:09:36Z","timestamp":1697116176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study"],"prefix":"10.3389","volume":"13","author":[{"given":"Ruihua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-3795","article-title":"Preclinical antitumor activity of a novel anti-C-kit antibody-drug conjugate against mutant and wild-type C-kit-positive solid tumors","volume":"24","author":"Abrams","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1368617","article-title":"Genomic subtypes of gists for stratifying patient response to sunitinib following imatinib resistance: A pooled analysis and systematic review","volume":"2018","author":"Tan","year":"2018","journal-title":"Dis Markers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000491799","article-title":"Surgery for gastrointestinal stromal tumors: state of the art of laparoscopic resection and surgery for M1 tumors","volume":"34","author":"Ronellenfitsch","year":"2018","journal-title":"Visc Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.08.20","article-title":"Gastrointestinal stromal tumors: A comprehensive review","volume":"10","author":"Parab","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: A randomised, double-blind, placebo-controlled trial","volume":"373","author":"Dematteo","year":"2009","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b05680","article-title":"Nobiletin down-regulates C-kit gene expression and exerts anti-leukemic effects on human acute myeloid leukemia cells","volume":"66","author":"Chen","year":"2018","journal-title":"J Agric Food Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-021-09961-7","article-title":"Gastrointestinal stromal tumor: A review of current and emerging therapies","volume":"40","author":"Al-Share","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-1858","article-title":"Robust activity of avapritinib, potent and highly selective inhibitor of mutated kit, in patient-derived xenograft models of gastrointestinal stromal tumors","volume":"25","author":"Gebreyohannes","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9705","article-title":"Gastrointestinal stromal tumors","volume":"36","author":"von Mehren","year":"2018","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/srep13718","article-title":"Clinicopathological significance of C-kit mutation in gastrointestinal stromal tumors: A systematic review and meta-analysis","volume":"5","author":"Yan","year":"2015","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.17.4284","article-title":"Correlation of kinase genotype and clinical outcome in the north american intergroup phase iii trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: calgb 150105 study by cancer and leukemia group B and southwest oncology group","volume":"26","author":"Heinrich","year":"2008","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5751","article-title":"Effect of kit and pdgfra mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: an exploratory analysis of a randomized clinical trial","volume":"3","author":"Joensuu","year":"2017","journal-title":"JAMA Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s101858","article-title":"A meta-analysis of prognostic value of kit mutation status in gastrointestinal stromal tumors","volume":"9","author":"Jiang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.21037\/atm-21-3811","article-title":"Gastrointestinal stromal tumors: associations between contrast-enhanced ct images and kit exon 11 gene mutation","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.06.025","article-title":"Risk stratification of patients diagnosed with gastrointestinal stromal tumor","volume":"39","author":"Joensuu","year":"2008","journal-title":"Hum Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0581","article-title":"Prognostic significance of C-kit mutation in localized gastrointestinal stromal tumors","volume":"10","author":"Kim","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02911.x","article-title":"C-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors","volume":"18","author":"Kinoshita","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/01.mp.0000097365.72526.3e","article-title":"Gastrointestinal stromal tumors with internal tandem duplications in 3' End of kit juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course","volume":"16","author":"Lasota","year":"2003","journal-title":"Mod Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2017.04.01","article-title":"Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor","volume":"29","author":"Li","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3390\/cancers13133158","article-title":"Recent progress and challenges in the diagnosis and treatment of gastrointestinal stromal tumors","volume":"13","author":"Nishida","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.19.554","article-title":"Deletions affecting codons 557-558 of the C-kit gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: A study by the spanish group for sarcoma research (Geis)","volume":"23","author":"Mart\u00edn","year":"2005","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000335","article-title":"Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of kit\/pdgfra genes and novel genomic alterations: results from a 20-year cohort of patients with gist from north-western Greece","volume":"3","author":"Mavroeidis","year":"2018","journal-title":"ESMO Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","article-title":"Gastrointestinal stromal tumors: pathology and prognosis at different sites","volume":"23","author":"Miettinen","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trecan.2017.11.006","article-title":"Gastrointestinal stromal tumors: the gist of precision medicine","volume":"4","author":"Mei","year":"2018","journal-title":"Trends Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020194","article-title":"Update on molecular genetics of gastrointestinal stromal tumors","volume":"11","author":"Br\u010di\u0107","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/sajc.sajc_275_16","article-title":"Unraveling the spectrum of kit mutations in gastrointestinal stromal tumors: an Indian tertiary cancer center experience","volume":"6","author":"Pai","year":"2017","journal-title":"South Asian J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12603","article-title":"Prognostic significance of kit exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor","volume":"13","author":"Quek","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4060","article-title":"Efficacy and tolerability of 5-year adjuvant imatinib treatment for patients with resected intermediate- or high-risk primary gastrointestinal stromal tumor: the persist-5 clinical trial","volume":"4","author":"Raut","year":"2018","journal-title":"JAMA Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2613","article-title":"Analysis of mutation of the C-kit gene and pdgfra in gastrointestinal stromal tumors","volume":"10","author":"Xu","year":"2015","journal-title":"Exp Ther Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00504","article-title":"Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after R0-resection","volume":"7","author":"Schmieder","year":"2016","journal-title":"Front Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0473-9","article-title":"Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy","volume":"451","author":"Wardelmann","year":"2007","journal-title":"Virchows Arch"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11323","article-title":"Deletion of trp-557 and lys-558 in the juxtamembrane domain of the C-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors","volume":"106","author":"Wardelmann","year":"2003","journal-title":"Int J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9320","article-title":"Clinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in chinese patients","volume":"16","author":"Yang","year":"2018","journal-title":"Oncol Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-018-6564-7","article-title":"Clinicopathological features and prognosis of 276 cases of primary small (\u2264\u20092 cm) gastric gastrointestinal stromal tumors: A multicenter data review","volume":"33","author":"Yang","year":"2019","journal-title":"Surg Endosc"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1272046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:09:38Z","timestamp":1697116178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1272046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":35,"alternative-id":["10.3389\/fonc.2023.1272046"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1272046","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"article-number":"1272046"}}